fbpx

Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market – Global Industry Analysis, Trends, Market Size, and Forecasts to 2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to ResearchAndMarkets.com’s offering.

The report on the global chronic obstructive pulmonary disease therapeutics market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on chronic obstructive pulmonary disease therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on chronic obstructive pulmonary disease therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global chronic obstructive pulmonary disease therapeutics market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global chronic obstructive pulmonary disease therapeutics market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Persistent rise in the number of COPD cases globally
  • Increasing the number of tobacco smokers and prolong exposure to polluted air environments

2) Restraints

  • Lack of knowledge and awareness regarding COPD indication and symptoms

3) Opportunities

  • Strong pipeline drugs and rising government initiatives

Key Topics Covered:

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Chronic Obstructive Pulmonary Disease Therapeutics Market Highlights

2.2. Chronic Obstructive Pulmonary Disease Therapeutics Market Projection

2.3. Chronic Obstructive Pulmonary Disease Therapeutics Market Regional Highlights

3. Global Chronic Obstructive Pulmonary Disease Therapeutics Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Drug Class

3.4.2. Growth Matrix Analysis by Distribution Channel

3.4.3. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Chronic Obstructive Pulmonary Disease Therapeutics Market

4. Chronic Obstructive Pulmonary Disease Therapeutics Market Macro Indicator Analysis

5. Global Chronic Obstructive Pulmonary Disease Therapeutics Market by Drug Class

5.1. Bronchodilators

5.2. Combination

5.3. Phosphodiesterase Type 4 Inhibitors

5.4. Mucokinetics

5.5. Corticosteroids

5.6. Other Drug Class

6. Global Chronic Obstructive Pulmonary Disease Therapeutics Market by Distribution Channel

6.1. Online Pharmacies

6.2. Hospital Pharmacies

6.3. Retail Pharmacies

7. Global Chronic Obstructive Pulmonary Disease Therapeutics Market by Region 2019-2025

7.1. North America

7.1.1. North America Chronic Obstructive Pulmonary Disease Therapeutics Market by Drug Class

7.1.2. North America Chronic Obstructive Pulmonary Disease Therapeutics Market by Distribution Channel

7.1.3. North America Chronic Obstructive Pulmonary Disease Therapeutics Market by Country

7.2. Europe

7.3. Asia-Pacific

7.4. RoW

8. Company Profiles and Competitive Landscape

8.1. Competitive Landscape in the Global Chronic Obstructive Pulmonary Disease Therapeutics Market

8.2. Companies Profiles

8.2.1. Pfizer Inc.

8.2.2. Adamis Laboratories, Inc.

8.2.3. AstraZeneca plc

8.2.4. Boehringer Ingelheim Pharmaceuticals, Inc.

8.2.5. Novartis AG

8.2.6. Sunovion Pharmaceuticals, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/urxg6i

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics: Respiratory Drugs

leverton

I have been involved with publishing and marketing for the past 37 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard. For people who love to save money and earn while saving, there is a new program called the r network. You are provided with a card that entitles the user to automatic savings on more than 300,000 products. Learn more about the revv card today. This is by invitation only to be some of the first people to get this card. I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice". Contact me directly at [email protected] for scheduling information.

You May Also Like